Alta Advisers’s Gilead Sciences GILD Stock Holding History

Alta Advisers’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$631K	Hold	4,992	–	–	0.14%	72
2026 Q1	$696K	Hold	4,992	–	–	0.25%	61
2025 Q4	$613K	Sell	4,992 -1,600	-24%	-$194K	0.22%	75
2025 Q3	$732K	Hold	6,592	–	–	0.22%	79
2025 Q2	$731K	Hold	6,592	–	–	0.26%	73
2025 Q1	$739K	Buy	6,592 +2,400	+57%	+$248K	0.31%	65
2024 Q4	$387K	Buy	4,192 +592	+16%	+$53.3K	0.24%	82
2024 Q3	$302K	Hold	3,600	–	–	0.14%	93
2024 Q2	$247K	Hold	3,600	–	–	0.12%	99
2024 Q1	$264K	Hold	3,600	–	–	0.13%	99
2023 Q4	$292K	Hold	3,600	–	–	0.16%	78
2023 Q3	$270K	Hold	3,600	–	–	0.16%	76
2023 Q2	$277K	Hold	3,600	–	–	0.16%	76
2023 Q1	$299K	Hold	3,600	–	–	0.18%	69
2022 Q4	$309K	Hold	3,600	–	–	0.19%	66
2022 Q3	$222K	Buy	+3,600	New	+$227K	0.14%	79
2013 Q4	–	Sell	-475	Closed	-$30K	–	56
2013 Q3	$30K	Sell	475 -591	-55%	-$35.3K	0.01%	50
2013 Q2	$55K	Buy	+1,066	New	+$55.6K	0.02%	50

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alta Advisers's GILD Position: Q2 2026 in Review

Alta Advisers held its Gilead Sciences (GILD) position steady in Q2 2026 at 4,992 shares worth $631K. The position accounts for 0.14% of the portfolio, ranked #72.

Alta Advisers first reported a position in GILD in Q2 2013 and has held it in 18 quarters since. The position peaked at $739K in Q1 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Alta Advisers held 4,992 shares of Gilead Sciences worth $631K as of Q2 2026.
Alta Advisers left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.14% of Alta Advisers's portfolio in Q2 2026, its #72 holding.
Alta Advisers first reported a position in Gilead Sciences in Q2 2013 and has held it in 18 quarters since.
Alta Advisers's Gilead Sciences position peaked at $739K in Q1 2025.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Alta Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.